Analyst consensus rating
Strata Critical Medical Analyst Rating: none
SRTA is rated none by 4 analysts with a $9.56 target. As of 2026-08-24.
Direct answer
Strata Critical Medical's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.56.
Forecast evidence checked August 24, 2026.
Get free Strata Critical Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $5.90
- Average price target
- $9.56
- High price target
- $12.75
- Low price target
- $8.00
- Low target gap
- +35.6%
- Target upside
- +62.1%
- High target gap
- +116.1%
- Target range width
- 80.5%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Strata Critical Medical?
Strata Critical Medical has a verified none consensus. The same dataset has an average price target of $9.56.
How far are Strata Critical Medical's low and high targets from the recorded price?
The low target implies +35.6%, while the high target implies +116.1%.
How many analysts are included in Strata Critical Medical's consensus?
The verified consensus includes 4 analysts.
How is Strata Critical Medical's target upside or downside calculated?
The average target of $9.56 is divided by the recorded price of $5.90, then one is subtracted to produce +62.1%. This does not guarantee a future return.
When was Strata Critical Medical's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.